Abstract

Although interposition soft-tissue (biologic) resurfacing of the glenoid with humeral hemiarthroplasty has been considered an option for end-stage glenohumeral arthritis, the results of this procedure are highly unsatisfactory in patients less than 40 years old. Achilles tendon allograft is popular for glenoid resurfacing because it can be made robust by folding it. But one reason that the procedure might fail in younger patients is that the graft is not initially thick enough for the young active patient. Most authors report folding the graft only once to achieve two-layer thickness. We report the case of a 30-year-old male who had postarthroscopic glenohumeral chondrolysis that was treated with Achilles tendon allograft resurfacing of the glenoid and humeral hemiarthroplasty. An important aspect of our case is that the tendon was folded so that it was 50–100% thicker than most allograft constructs reported previously. We also used additional measures to enhance allograft resiliency and bone incorporation: (1) multiple nonresorbable sutures to attach the adjacent graft layers, (2) additional resorbable suture anchors and nonresorbable sutures in order to more robustly secure the graft to the glenoid, and (3) delaying postoperative motion and strengthening. However, despite these additional measures, our patient did not have an improved outcome.

Highlights

  • Interposition biologic resurfacing of the glenoid with stemmed humeral hemiarthroplasty or humeral head resurfacing is an option for younger patients with end-stage glenohumeral arthritis [1,2,3]

  • We report the case of a 30-year-old male who had intraarticular pain-pump catheter associated (PPCA) postarthroscopic glenohumeral chondrolysis (PAGCL) that was treated with Achilles tendon allograft resurfacing of the glenoid and conventional humeral hemiarthroplasty

  • We suggest that in patients with PPCA PAGCL their glenohumeral inflammation is much more unfavorable to the biological assimilation/incorporation of an allograft when compared to patients with typical degenerative arthritis

Read more

Summary

Introduction

Interposition biologic (soft-tissue) resurfacing of the glenoid with stemmed humeral hemiarthroplasty (i.e., conventional hemiarthroplasty) or humeral head resurfacing is an option for younger patients with end-stage glenohumeral arthritis [1,2,3]. Krishnan et al [5] advocated folding the tendon to achieve three- to fourlayer thickness They reported on 34 patients (mean age 51) who had soft-tissue resurfacing and conventional humeral hemiarthroplasty. 10 (77%) of patients reported by Elhassan et al did poorly, being converted to a total shoulder arthroplasty (TSA) at a mean of 14 months after surgery Besides our case, these other studies did not have patients with intra-articular pain-pump catheter associated (PPCA) postarthroscopic glenohumeral chondrolysis (PAGCL). Muh et al [3] reported unsatisfactory outcomes (38% converted to TSA) in their relatively younger patients (n = 16; mean 36 years old) who had conventional hemiarthroplasty with soft-tissue resurfacing of the glenoid. We report the case of a 30-year-old male who had intraarticular pain-pump catheter associated (PPCA) postarthroscopic glenohumeral chondrolysis (PAGCL) that was treated with Achilles tendon allograft resurfacing of the glenoid and conventional humeral hemiarthroplasty. Even with these modifications, our patient had a poor result, being converted to a TSA two years later

Case Report
Discussion
Findings
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call